Synthace

Synthace operates at the intersection of AI, synthetic biology, and digital health, offering a software-driven platform to optimize biological experimentation. Its core value proposition is reducing the time and cost of assay development and process optimization by enabling sophisticated Design of Experiments (DOE) and automating execution on lab equipment. The company adopts a hybrid business model, selling its software alongside high-touch consulting and training services from its team of Field Application Scientists. Its target customers are R&D organizations seeking to increase throughput and reliability in early-stage discovery.

A cloud-based software platform for designing multivariate experiments (Design of Experiments/DOE), orchestrating their automated execution on lab dispensers/handlers, and structuring data for analysis. It integrates with existing lab hardware to create a digital workflow from experimental design to insight.

Synthace competes in the lab informatics and automation software space. Direct competitors include electronic lab notebook (ELN) and laboratory information management system (LIMS) providers like Benchling that are adding experiment design features. It also competes with software from automation hardware vendors (e.g., Tecan, Beckman) and specialized DOE software tools. Its differentiation is the combined focus on multivariate experimental methodology, automation orchestration, and deep domain expertise in biology.